Resolution 2009/6. Joint United Nations Programme on HIV/AIDS (UNAIDS)

6.  Reaffirms the right to use, to the full, the provisions contained in the Agreement on Trade-related Aspects of Intellectual Property Rights,6 the Doha Declaration on the Agreement on Trade-related Aspects of Intellectual Property Rights and Public Health,7 and the decision of the World Trade Organization General Council of 30 August 2003 on the implementation of paragraph 6 of the Doha Declaration on the TRIPS Agreement and public health,8 and, when formal acceptance procedures are completed, the amendment to article 31 of the Agreement, which provide flexibilities for the protection of public health, and, in particular, to promote access to medicines for all, and also calls for a broad and timely acceptance of the amendment to article 31 of the Agreement on Trade-related Aspects of Intellectual Property Rights, as proposed by the World Trade Organization General Council in its decision of 6 December 2005;
  • Access to controlled medicines

10. Urges Governments to prioritize and expand access to the prevention and treatment of HIV-related opportunistic infections, to promote access to and the effective use of safe and effective antiretroviral drugs of assured quality, at affordable prices, and to support both biomedical and socio-economic research on new products to prevent HIV infection, including those controlled by women, diagnostics, medicines and other treatment commodities and technologies related to HIV;
  • Harm reduction

19. Recognizes the need for the Joint Programme to significantly expand and strengthen its work with national Governments and to work with all groups of civil society to address the gap in access to services for injecting drug users in all settings, including prisons, to develop comprehensive models of appropriate service delivery for injecting drug users, to tackle the issues of stigmatization and discrimination, and to support increased capacity and resources for the provision of a comprehensive package of services for injecting drug users, including harm reduction programmes in relation to HIV, as elaborated in the WHO, UNODC, UNAIDS Technical Guide for Countries to Set Targets for Universal Access to HIV Prevention, Treatment and Care for Injecting Drug Users, in accordance with relevant national circumstances.
  • Harm reduction

View document